Archives
Denny's Announces $620 Million Take-Private Deal With TriArtisan-Led Group
Denny's agrees to a $620 million take-private deal led by TriArtisan, offering shareholders $6.25 per share.
Dietary Supplement Sold at Sam's Club Recalled as Salmonella Sickens 11 People
Sam's Club recalls all Member's Mark "Super Greens" powders after salmonella outbreak sickens 11 people across seven states.
Tesla Sales Crash in Europe While Rival EV Makers Surge Ahead
Tesla faces a sharp sales drop in Europe as rivals gain ground and legal challenges mount.
Procter & Gamble Hit With Lawsuit Claiming Kid's Crest Packaging Endangers Kids
Procter & Gamble faces a lawsuit claiming Kid's Crest packaging may lead children to use unsafe amounts of toothpaste.
Latest News
Kimberly-Clark's acquisition of Kenvue marks a major strategic shift as the company expands beyond its traditional personal care and diving deeper into the consumer health market.
Coca-Cola's new Christmas advertisement is very festive, but not all are impressed after the company proudly said they used fewer people for it.
Japan's biggest media companies accuse OpenAI of stealing anime and game content to train Sora 2. This is a new battle for the ChatGPT maker.
Baidu's Apollo Go hits 250,000 weekly robotaxi rides, matching Waymo and intensifying the China-US race in autonomous driving technology.
Udio gives users 48 hours to download AI-generated songs after settling a copyright dispute with Universal Music.
McDonald's CEO Chris Kempczinski crowns the Snack Wrap his favorite menu item in a viral LinkedIn video tournament.
Toy maker Learning Resources takes Donald Trump's sweeping tariffs to the U.S. Supreme Court, arguing the policy unfairly harms small American businesses.
Lufthansa avoids immediate pilot strike as union delays action over pension dispute.
Bitcoin trades near $110K (£90K) as traders await a decisive move. Experts say a break above $114K could spark a rally — or trigger a sharp correction.
Pfizer sues Metsera and Novo Nordisk to block a rival bid in a high-stakes obesity drug merger.

















